EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL)
Protocol No
P24-903
Trial information
Medical condition
3L+DLBCL/FL
Trial phase
Observational
Sponsor
AbbVie Inc.
Start date
21/03/2025
Main objective
ORR within 12 months
Locations and Contact points
Greece
Site city
Organisation name
Department name
Name
Email
Telephone number
Alexandroupolis
University General Hospital of Alexandroupolis
Hematology Clinic
Ioannis Kotsianidis
2551353154
Cookies and your privacy
We use essential cookies to make this site work. With your consent, we also use Google Analytics cookies to measure visits and improve the site. You can change your choice at any time.